Wedbush Estimates Arcus Biosciences’ Q2 Earnings (NYSE:RCUS)
Arcus Biosciences, Inc. (NYSE:RCUS – Free Report) – Wedbush dropped their Q2 2025 earnings per share estimates for shares of Arcus Biosciences in a research report issued to clients and investors on Wednesday, May 7th. Wedbush analyst R. Driscoll now forecasts that the company will post earnings of ($1.11) per share for the quarter, down […]
